IMM Investment's Biotechnology Portfolio

Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.

Mito Immune Therapeutics is a drug research and development biotech company.

Biotechnology, Neuorscience

ABL Bio is a biotech research company that focuses on the development of therapeutic drugs for immuno-oncology diseases.

Private biotech company creating cell penetrating therapeutic antibodies

Parataxis Korea specializes in Bitcoin treasury management.

Trioar is a biotechnological research company that manufacture pharmaceutical products and drugs.

Illimis Therapeutics is a science and technology company that develops treatment for degenerative brain and autoimmune diseases.

Inventera Pharmaceutical is a biotechnology company that specializes in the development of imaging diagnostic contrast agents.

​Cellemedy is a biotechnology company that develops next-generation therapeutic proteins to replace conventional antibody treatments.

IMBiologics is a biotechnology company that develops immunomodulatory antibody drugs for physiological balance.

Zymedi is a pharmaceutical company that develops drugs for life-threatening diseases.

Pinot Bio is a biotechnology company that specializes in developing new generation anticancer treatments.

Genome & Co (G&C) is a microbiome based research and development company focused on researching microbes and probiotics.

AbClon Inc. engages in the research and development of antibody drugs in South Korea and Sweden.

Spark Biopharma is a biotechnology company

Kobiolabs is a microbiome-based venture

Selecxine is a biopharmaceutical development company specialized in the field of immunotherapeutics.

BIORCHESTRA creates novel RNA-based therapeutics that will usher in a new era of treatment for neurodegenerative diseases.

Curocell’s OVIS™ technology enhances immune cells to overcome immune suppression in tumor microenvironments.

ExoStemTech is a biotechnology company that develops stem cell exosome therapeutics, plant exosomes, and anti-cancer drugs.

SCAI Therapeutics is a drug delivery platform bio-venture company for pharmaceutical industry.

J2H Biotech is a bio-venture company focusing on the development of small-molecule drugs for the treatment of intractable rare diseases.

GI Innovation is a global leader of microbiome drug development.

Geninus is a biotechnology company that provides clinical genome analysis solutions for precision medicine clinics.

NGeneBio provides in vitro diagnostics panel and clinical analysis software.

EuBiologics provides and develops biopharmaceutical products.